CODX Co-Diagnostics, Inc.
Healthcare$9.11+79.68%ClosedMarket Cap: $10.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.71
P/S
7.88
EV/EBITDA
0.02
DCF Value
$7.43
FCF Yield
-512.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
9.5%
Operating Margin
-4447.4%
Net Margin
-6753.7%
ROE
-164.9%
ROA
-225.6%
ROIC
-171.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $146.0K | -207.8% | $-9.2M | $-9.1M | $— | — |
| Q4 null | $263.9K | 46.0% | $-7.7M | $-25.7M | $— | — |
| FY null | $622.5K | 64.3% | $-31.3M | $-46.9M | $— | — |
| Q3 null | $145.4K | 81.9% | $-7.0M | $-5.9M | $— | — |
| Q2 null | $162.9K | 80.3% | $-8.1M | $-7.7M | $— | — |
| Q1 null | $50.3K | 57.1% | $-8.6M | $-7.5M | $— | — |
| Q4 null | $149.3K | -70.8% | $-11.9M | $-11.0M | $— | — |
| FY null | $3.9M | 74.5% | $-40.1M | $-37.6M | $— | — |
| Q3 null | $641.1K | 53.6% | $-10.2M | $-9.7M | $— | — |
| Q2 null | $2.7M | 92.0% | $-7.7M | $-7.6M | $— | — |
| Q1 null | $252.7K | 7.2% | $-10.3M | $-9.3M | $— | — |
| Q4 2023 | $3.6M | 16.5% | $-11.8M | $-14.7M | $-14.10 | — |